Yu et al. suggested a pro-tumorigenic role of DDX11 in xenograft cancer animal models and demonstrated that DDX11 overexpression leads to activation of PI3K/AKT/mTOR signaling pathway [29]. This evidence concerns the gene DDX11 and cancer.